Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Richard B Rothman

Showing results (141-150 of 159) with videos related to

Pageof 16
Sort By:
Medchemcomm|March 24, 2012
Potential Drug Abuse Therapeutics Derived from the Hallucinogenic Natural Product Salvinorin AKatherine M Prevatt-Smith, Kimberly M Lovell, Denise S Simpson, et al.
Bioorganic & Medicinal Chemistry|October 15, 2003
Diaryldimethylpiperazine ligands with mu- and delta-opioid receptor affinity: Synthesis of (+)-4-[(alphaR)-alpha-(4-allyl-(2S,5S)-dimethylpiperazin-1-yl)-(3-hydroxyphenyl)methyl]-N-ethyl-N-phenylbenzamide and (-)-4-[(alphaR)-alpha-(2S,5S)-dimethylpiperazin-1-yl)-(3-hydroxyphenyl)methyl]-N-ethyl-N-phenylbenzamideIn Jong Kim, Thomas Ullrich, James W Janetka, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|November 30, 2013
Evidence for a role of transporter-mediated currents in the depletion of brain serotonin induced by serotonin transporter substratesMichael H Baumann, Simon Bulling, Tova S Benaderet, et al.
The Journal of Pharmacology and Experimental Therapeutics|October 15, 2005
Depressive-like effects of the kappa-opioid receptor agonist salvinorin A on behavior and neurochemistry in ratsWilliam A Carlezon, Cécile Béguin, Jennifer A DiNieri, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|December 16, 2011
The designer methcathinone analogs, mephedrone and methylone, are substrates for monoamine transporters in brain tissueMichael H Baumann, Mario A Ayestas, John S Partilla, et al.
Journal of Medicinal Chemistry|June 22, 2007
Synthetic studies of neoclerodane diterpenes from Salvia divinorum: preparation and opioid receptor activity of salvinicin analoguesDenise S Simpson, Peter L Katavic, Anthony Lozama, et al.
Journal of Medicinal Chemistry|April 30, 2004
Synthesis and pharmacological evaluation of 3-(3,4-dichlorophenyl)-1-indanamine derivatives as nonselective ligands for biogenic amine transportersHan Yu, In Jong Kim, John E Folk, et al.
Journal of Medicinal Chemistry|April 3, 2008
Herkinorin analogues with differential beta-arrestin-2 interactionsKevin Tidgewell, Chad E Groer, Wayne W Harding, et al.
Journal of Medicinal Chemistry|March 3, 2006
Design and synthesis of promiscuous high-affinity monoamine transporter ligands: unraveling transporter selectivityElisabeth Greiner, Terrence L Boos, Thomas E Prisinzano, et al.
Bioorganic & Medicinal Chemistry|November 28, 2006
DAT/SERT selectivity of flexible GBR 12909 analogs modeled using 3D-QSAR methodsKathleen M Gilbert, Terrence L Boos, Christina M Dersch, et al.
Pageof 16

Showing results (141-150 of 159) with videos related to

Sort By:
Pageof 16
Medchemcomm|March 24, 2012
Potential Drug Abuse Therapeutics Derived from the Hallucinogenic Natural Product Salvinorin AKatherine M Prevatt-Smith, Kimberly M Lovell, Denise S Simpson, et al.
Bioorganic & Medicinal Chemistry|October 15, 2003
Diaryldimethylpiperazine ligands with mu- and delta-opioid receptor affinity: Synthesis of (+)-4-[(alphaR)-alpha-(4-allyl-(2S,5S)-dimethylpiperazin-1-yl)-(3-hydroxyphenyl)methyl]-N-ethyl-N-phenylbenzamide and (-)-4-[(alphaR)-alpha-(2S,5S)-dimethylpiperazin-1-yl)-(3-hydroxyphenyl)methyl]-N-ethyl-N-phenylbenzamideIn Jong Kim, Thomas Ullrich, James W Janetka, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|November 30, 2013
Evidence for a role of transporter-mediated currents in the depletion of brain serotonin induced by serotonin transporter substratesMichael H Baumann, Simon Bulling, Tova S Benaderet, et al.
The Journal of Pharmacology and Experimental Therapeutics|October 15, 2005
Depressive-like effects of the kappa-opioid receptor agonist salvinorin A on behavior and neurochemistry in ratsWilliam A Carlezon, Cécile Béguin, Jennifer A DiNieri, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|December 16, 2011
The designer methcathinone analogs, mephedrone and methylone, are substrates for monoamine transporters in brain tissueMichael H Baumann, Mario A Ayestas, John S Partilla, et al.
Journal of Medicinal Chemistry|June 22, 2007
Synthetic studies of neoclerodane diterpenes from Salvia divinorum: preparation and opioid receptor activity of salvinicin analoguesDenise S Simpson, Peter L Katavic, Anthony Lozama, et al.
Journal of Medicinal Chemistry|April 30, 2004
Synthesis and pharmacological evaluation of 3-(3,4-dichlorophenyl)-1-indanamine derivatives as nonselective ligands for biogenic amine transportersHan Yu, In Jong Kim, John E Folk, et al.
Journal of Medicinal Chemistry|April 3, 2008
Herkinorin analogues with differential beta-arrestin-2 interactionsKevin Tidgewell, Chad E Groer, Wayne W Harding, et al.
Journal of Medicinal Chemistry|March 3, 2006
Design and synthesis of promiscuous high-affinity monoamine transporter ligands: unraveling transporter selectivityElisabeth Greiner, Terrence L Boos, Thomas E Prisinzano, et al.
Bioorganic & Medicinal Chemistry|November 28, 2006
DAT/SERT selectivity of flexible GBR 12909 analogs modeled using 3D-QSAR methodsKathleen M Gilbert, Terrence L Boos, Christina M Dersch, et al.
Pageof 16